FIB-4与NAFLD纤维化评分在人群肝纤维化筛查中准确性低
该研究纳入5个独立人群队列共5129例,评估FIB-4与NFS检测肝硬度升高(8 kPa和12 kPa)的准确性。约11%参与者肝硬度≥8 kPa,其中43% FIB-4正常、31% NFS正常;假阴性在风险人群更高。FIB-4和NFS因过度诊断和不可忽视的假阴性而不适合筛查,腰围在一般人群中表现更优。
要点
- 肝硬度≥8 kPa者中43% FIB-4正常、31% NFS正常,假阴性不可忽视。
- 风险人群假阴性比例高于一般人群,糖尿病患者FIB-4假阴性11% vs NFS 2.5%。
- 一般人群中腰围检测肝硬度≥8 kPa优于FIB-4和NFS。
核心结论
- FIB-4和NFS因过度诊断风险高和不可忽视的假阴性比例而不适合筛查,尤其在慢性肝病风险因素患者中。
- 腰围可作为一般人群中识别肝纤维化风险患者的潜在第一步。
研究设计与样本
- 研究纳入5个独立人群队列(西班牙、香港、丹麦、英格兰和法国)共5129例,其中一般人群3979例,因酒精、糖尿病或肥胖的风险队列1150例。
- 所有参与者同时测量FIB-4、NFS和Fibroscan肝硬度(LSM),分析FIB-4和NFS检测LSM≥8 kPa和≥12 kPa的检验前后预测值。
- 平均年龄53±12岁,平均体重指数27±5 kg/m2,女性2439例(57%)。
主要发现
- 552例(11%)肝硬度≥8 kPa,其中239例(43%)FIB-4正常,171例(31%)NFS正常。
- 风险人群假阴性比例高于一般人群;糖尿病患者FIB-4假阴性11%,NFS假阴性2.5%。
- 一般人群中腰围检测LSM≥8 kPa优于FIB-4和NFS。
- 一般人群和风险队列中FIB-4/NFS升高的假阳性率均为28%-29%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Fibrosis-4 (FIB-4) and the nonalcoholic fatty liver disease fibrosis score (NFS) are the 2 most popular noninvasive blood-based serum tests proposed for widespread fibrosis screening. We therefore aimed to describe the accuracy of FIB-4 and NFS to detect elevated liver stiffness as an indicator of hepatic fibrosis in low-prevalence populations. METHODS: This study included a total of 5129 patients with concomitant measurement of FIB-4, NFS, and liver stiffness measurement (LSM) by Fibroscan (Echosens, France) from 5 independent population-based cohorts from Spain, Hong Kong, Denmark, England, and France; 3979 participants from the general population and 1150 from at-risk cohorts due to alcohol, diabetes, or obesity. We correlated LSM with FIB-4 and NFS, and calculated pre- and post-test predictive values of FIB-4 and NFS to detect elevated LSM at 8 kPa and 12 kPa cutoffs. The mean age was 53 ± 12 years, the mean body mass index was 27 ± 5 kg/m2, and 2439 (57%) were women. One in 10 patients (552; 11%) had liver stiffness ≥8 kPa, but 239 of those (43%) had a normal FIB-4, and 171 (31%) had normal NFS. The proportion of false-negatives was higher in at-risk patients than the general population. FIB-4 was false-negative in 11% of diabetic subjects, compared with 2.5% false-negatives with NFS. Waist circumference outperformed FIB-4 and NFS for detecting LSM ≥8 kPa in the general population. Almost one-third (28%-29%) of elevated FIB-4/NFS were false-positive in both the general population and at-risk cohorts. CONCLUSIONS: FIB-4 and NFS are suboptimal for screening purposes due to a high risk of overdiagnosis and a non-negligible percentage of false-negatives, especially in patients with risk factors for chronic liver disease. Waist circumference emerged as a potential first step to identify patients at risk for liver fibrosis in the general population.
引用
- Graupera I, Thiele M, Serra-Burriel M, et al. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. Clin Gastroenterol Hepatol. 2021. PMID: 34971806. doi:10.1016/j.cgh.2021.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。